| Literature DB >> 14741344 |
Youn-Hee Choi1, Ha-il Kim, Je Kyung Seong, Dae-Yeul Yu, Hyeseong Cho, Mi-Ock Lee, Jae Myun Lee, Yong-ho Ahn, Se Jong Kim, Jeon Han Park.
Abstract
Ligand activation of peroxisome proliferator-activated receptor gamma (PPARgamma) has been reported to induce growth inhibition and apoptosis in various cancers including hepatocellular carcinoma (HCC). However, the effect of hepatitis B virus X protein (HBx) on PPARgamma activation has not been characterized in hepatitis B virus (HBV)-associated HCC. Herein, we demonstrated that HBx counteracted growth inhibition caused by PPARgamma ligand in HBx-associated HCC cells. We found that HBx bound to DNA binding domain of PPARgamma and HBx/PPARgamma interaction blocked nuclear localization and binding to recognition site of PPARgamma. HBx significantly suppressed a PPARgamma-mediated transactivation. These results suggest that HBx modulates PPARgamma function through protein-protein interaction.Entities:
Mesh:
Substances:
Year: 2004 PMID: 14741344 DOI: 10.1016/s0014-5793(03)01449-2
Source DB: PubMed Journal: FEBS Lett ISSN: 0014-5793 Impact factor: 4.124